We are live on ! Find out more
BSA

Braun Stacey Associates Portfolio holdings

AUM $3.53B
1-Year Est. Return 63.32%
This Fund
S&P 500
This Quarter Est. Return
+11.53%
1 Year Est. Return
+63.32%
3 Year Est. Return
+230.74%
5 Year Est. Return
+346.7%
10 Year Est. Return
+1,599.29%
AUM
$1.75B
AUM Growth
+$107M
Cap. Flow
-$18.2M
Cap. Flow %
-1.04%
Top 10 Hldgs %
22.6%
Holding
135
New
16
Increased
32
Reduced
65
Closed
19

Top Buys

Rank Stock Value
1
PWR icon
Quanta Services
PWR
+$21.2M
2
TRV icon
Travelers Companies
TRV
+$20.2M
3
CI icon
Cigna
CI
+$18.8M
4
LDOS icon
Leidos
LDOS
+$14.5M
5
CELH icon
Celsius Holdings
CELH
+$14.4M

Top Sells

Rank Stock Value
1
CVS icon
CVS Health
CVS
+$18.5M
2
BX icon
Blackstone
BX
+$18.3M
3
WMS icon
Advanced Drainage Systems
WMS
+$15.6M
4
FFIV icon
F5
FFIV
+$12.3M
5
DOW icon
Dow Inc
DOW
+$9.79M

Sector Composition

Rank Sector Weight
1 Technology 21.76%
2 Healthcare 16.27%
3 Financials 12.81%
4 Industrials 10.24%
5 Consumer Staples 9.21%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
MAR icon
51
Marriott International
MAR
$92.3B
$16.3M 0.93%
109,287
-5,138
-4% -$791K
CELH icon
52
Celsius Holdings
CELH
$7.03B
$15.4M 0.88%
+442,692
New +$14.4M
DHR icon
53
Danaher
DHR
$144B
$15.2M 0.86%
64,390
-9,580
-13% -$2.22M
LDOS icon
54
Leidos
LDOS
$17.3B
$14.8M 0.85%
+141,140
New +$14.5M
BLK icon
55
Blackrock
BLK
$176B
$14.8M 0.85%
20,906
-1,434
-6% -$958K
TMO icon
56
Thermo Fisher Scientific
TMO
$220B
$14.7M 0.84%
26,612
-2,936
-10% -$1.56M
REGN icon
57
Regeneron Pharmaceuticals
REGN
$80.8B
$14M 0.8%
19,376
-161
-0.8% -$119K
AEE icon
58
Ameren
AEE
$30.1B
$13.8M 0.79%
155,284
+6,145
+4% +$516K
NVDA icon
59
NVIDIA
NVDA
$5.42T
$13.6M 0.78%
934,020
+33,830
+4% +$496K
LRCX icon
60
Lam Research
LRCX
$390B
$13.6M 0.78%
324,330
+23,360
+8% +$977K
CMI icon
61
Cummins
CMI
$88.7B
$13.5M 0.77%
55,801
-903
-2% -$215K
WFC icon
62
Wells Fargo
WFC
$264B
$13.4M 0.77%
325,433
-21,105
-6% -$934K
AWK icon
63
American Water Works
AWK
$26.9B
$13M 0.74%
85,591
+3,840
+5% +$554K
TKR icon
64
Timken Company
TKR
$9.03B
$12.9M 0.74%
+182,727
New +$12.8M
CSL icon
65
Carlisle Companies
CSL
$15.4B
$12.8M 0.73%
54,372
-20,523
-27% -$5.28M
HD icon
66
Home Depot
HD
$355B
$12.8M 0.73%
40,500
-3,533
-8% -$1.08M
STZ icon
67
Constellation Brands
STZ
$23.2B
$12.5M 0.71%
53,733
-15,520
-22% -$3.71M
GPN icon
68
Global Payments
GPN
$22.8B
$12.4M 0.71%
124,968
-31,302
-20% -$3.26M
ACN icon
69
Accenture
ACN
$108B
$12.1M 0.69%
45,268
-3,713
-8% -$1.03M
CTVA icon
70
Corteva
CTVA
$51.3B
$12M 0.68%
+203,557
New +$12.9M
ABBV icon
71
AbbVie
ABBV
$435B
$11.9M 0.68%
73,762
-9,773
-12% -$1.5M
VRT icon
72
Vertiv
VRT
$105B
$11.6M 0.66%
+852,550
New +$11.4M
COST icon
73
Costco
COST
$420B
$11.6M 0.66%
25,394
-836
-3% -$409K
UTHR icon
74
United Therapeutics
UTHR
$23.1B
$11.5M 0.66%
+41,369
New +$10.4M
MANH icon
75
Manhattan Associates
MANH
$11.4B
$11.1M 0.63%
91,352
-6,195
-6% -$762K

Similar funds

Braun Stacey Associates's Q4 2022 Portfolio in Review

As of Q4 2022, Braun Stacey Associates held 135 positions worth $1.75B, up 6.5% from $1.65B the previous quarter. Its ten largest holdings account for 23% of the portfolio.

Braun Stacey Associates's Q4 2022 filing shows 16 new, 32 increased, 65 reduced and 19 closed positions. Its largest new stake was Quanta Services: 149,611 shares worth $21.3M. The largest sale was CVS Health, an estimated $18.5M.

By sector, the portfolio is most concentrated in Technology at 22% of assets, down from 23% a quarter earlier, followed by Healthcare and Financials.

  • Braun Stacey Associates's largest Q4 2022 buy was Quanta Services: 149,611 shares worth $21.3M.
  • Braun Stacey Associates added most to Halozyme in Q4 2022, an estimated $4.81M increase.
  • Braun Stacey Associates's biggest Q4 2022 reduction was Zoetis, cutting an estimated $7.1M.
  • Braun Stacey Associates fully exited CVS Health in Q4 2022, selling an estimated $18.5M.
  • Braun Stacey Associates's ten largest holdings make up 23% of its $1.75B portfolio in Q4 2022.
  • Braun Stacey Associates opened 16 new positions and closed 19 in Q4 2022.
  • Braun Stacey Associates's portfolio value rose 6.5% quarter-over-quarter to $1.75B.

Based on Braun Stacey Associates's 13F filing for Q4 2022, filed 7 Feb 2023.